Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial.

Clicks: 432
ID: 46480
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #2 of 5 articles by views in eurointervention : journal of europcr in collaboration with the working group on interventional cardiology of the european society of cardiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
To prospectively assess clinical benefits of fractional flow reserve (FFR) in guiding coronary artery bypass grafting (CABG).GRAFFITI is a single-blinded prospective multicenter randomized controlled trial for FFR-guided versus angiography-guided CABG. We enrolled patients, undergoing coronary angiography, having significantly diseased left anterior descending or left main stem and at least one more major coronary artery with intermediate stenosis, assessed by FFR. Surgical strategy was defined based on angiogram, blinded to FFR values prior to randomization. After randomization, patients were either operated following the angiogram-based strategy (Angiography-guided group) or according to FFR: i.e. with FFR≤0.80 as cut-off for grafting (FFR-guided group). Primary endpoint was graft patency at 12 months. Trial was registered (NCT01810224). Between March 2012 and December 2016, 172 patients were randomized either to angiography-guided (84 patients) or to FFR-guided group (88 patients). Patients had median of 3 [3;4] lesions. Diameter stenosis was 65% [50%;80%], FFR was 0.72 [0.50;0.82]. Compared to angiography-guided group, FFR-guided group received less anastomoses (3 [3;3] vs. 2 [2;3] respectively; p=0.004). One-year angiographic follow-up showed no difference in overall graft patency (126 [80%] vs 113 [81%], respectively; p=0.885). One-year clinical follow-up, available in 98% of patients, showed no difference in composite of death, myocardial infarction, target vessel revascularization and stroke.FFR-guidance of CABG has no impact on 1-year graft patency, but it is associated with a simplified surgical procedure.
Reference Key
toth2019grafteurointervention Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Toth, Gabor G;De Bruyne, Bernard;Kala, Petr;Ribichini, Flavio L;Casselman, Filip;Ramos, Ruben;Piroth, Zsolt;Fournier, Stephane;Piccoli, Anna;Van Mieghem, Carlos;Penicka, Martin;Mates, Martin;Nemec, Petr;Van Praet, Frank;Stockman, Bernard;Degriek, Ivan;Barbato, Emanuele;
Journal eurointervention : journal of europcr in collaboration with the working group on interventional cardiology of the european society of cardiology
Year 2019
DOI
EIJ-D-19-00463
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.